Quick Answer
Praxis Precision Medicines, Inc. reported Net Income of -$303.27 million for fiscal year 2025.
Praxis Precision Medicines, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$303.27M | -65.9% |
| 2024 | -$182.82M | -48.3% |
| 2023 | -$123.28M | +42.4% |
| 2022 | -$214.03M | -28.1% |
| 2021 | -$167.06M | -170.2% |
| 2020 | -$61.82M | -74.1% |
| 2019 | -$35.51M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$73.93M | -42.4% | -3.9% |
| June 30, 2025 | -$71.13M | -117.7% | -2.6% |
| March 31, 2025 | -$69.30M | -75.2% | -33.5% |
| September 30, 2024 | -$51.91M | -110.7% | -58.9% |
| June 30, 2024 | -$32.68M | +4.8% | +17.4% |
| March 31, 2024 | -$39.55M | -5.6% | -60.6% |
| September 30, 2023 | -$24.63M | +43.9% | +28.2% |
| June 30, 2023 | -$34.31M | +43.0% | +8.4% |
- Praxis Precision Medicines, Inc. showed a decrease of -65.9% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Praxis Precision Medicines, Inc.’s net income has declined by 754.0% (from -$35.51 million to -$303.27 million).
- The most recent figure is from Praxis Precision Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: